Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 173 results for "keshavan"

Product and book launches

Olympian luger Shiva Keshavan, Farhan Akhtar, Sabyasachi Mukherjee and Atul Kasbekar at the launch of a new product by a leading beverage brand. Also in the frame: Venkatesh Kini and Debabrata Mukherjee of Coca Cola; Manpreet Gulri of Subway and ... Economic Times, 6 days ago

5 images for keshavan

MedCity News, 2 months ago
MedCity News, 3 months ago
Think Digit, 4 months ago
89.3 KPCC, 4 months ago
Times of Oman, 5 months ago

"Naming a brand like this is more complex than people realise": Sujata Keshavan on Vistara

Sujata Keshavan chairperson and executive creative director, Ray+Keshavan We interviewed Sujata Keshavan, chairperson and executive creative director of Ray+Keshavan, the design agency that helped create brand Vistara. Q. Did the brief require you to keep the ...
 Afaqs1 month ago

Ray + Keshavan | Brand Union creates Tata Singapore Airlines Vistara brand

The agency was mandated to develop the airline's strategy, name, visual identity and brand experience BestMediaInfo Bureau | Mumbai | August 13, 2014 The Tatas are once again entering the Indian aviation space, this time with Singapore ...
 Best Media Info1 month ago Pushing back boundaries for a historic partnership  This Week Bangalore1 month ago Experts divided on Vistara brand appeal  Livemint.com1 month ago

On Twitter: Who are the most social media-savvy scientists in health care?

Science Magazine recently posted a list of the top 50 scientists on Twitter . Here arethe top social media-savvy thinkers that contribute to the health care space: 1. Ben Goldacre, @bengoldacre 325K followers, 47.4K tweets The British docis ...
 MedCity News15 hours ago #Act4NIH: Social media push underway to restore research funding at NIH  MedCity News1 week ago How scientists are using social media, and why ResearchGate is dominating  MedCity News1 month ago

NPR: Ebola researchers have radical idea to rush vaccine into the field

The World Health Organization just finished up a two-day meeting to debate whether they should allow an Ebola vaccine to be administered in the field without having tested efficacy, NPR reports . The disease's spread is alarming , and traditional ...
 MedCity News1 day ago

Orthopedics maker raises $8M to expand hip and knee joint offerings

Consensus Orthopedics justraised $8 million from Los Angeles-based Breakwater Investment Funds , CEO Colleen Gray said, to be used as growth capital. Hip and knee replacements are a pretty capital-intensive business, Gray said. Were doing this so ...
 MedCity News1 day ago

NIH commits $46M to BRAIN Initiative researchers around the world

The NIH has just committed $46 million toward the White House's BRAIN Initiative, with aims to delve deeper into understanding what makes the human mind and brain tick. The government justannounced the 58 research centers andacademics to whom the ...
 MedCity News1 day ago

GSK commits $5M to startups, academics that develop bioelectronics

GlaxoSmithKline has just launcheda $5 million Innovation Challenge Fund to advance open-access technology in the bioelectronics space. The funding's aimed toward biz-savvyacademicsand startups that are working to create a new class of treatments ...
 MedCity News1 day ago

Worldwide market for biosimilars at its tipping point

Worldwide growthin the biosimilars market is hitting its tipping point, analysts say. Sales are projected to hit $25 billion by 2020, according to thefolks over at BioWorld who put together a new report, Biosimilars: A Global Perspective of a New ...
 MedCity News1 day ago Epirus arthritis biosimilar approval in India indicative of its international focus  MedCity News2 weeks ago

Xeris developing glucagon product for diabetes control, raises $7.2M

An Austin-based company that's developing the blood sugar-regulating hormone glucagon, as opposed to insulin, is in the midst of a decent-sized Series B deal. Xeris Pharmaceuticals has raised $7.2 million in Series B funding, according to a ...
 MedCity News2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less